ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 696921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 696921; 2) Community: the network communities that were significantly associated with the response to NSC 696921; 3) Molecule: the relationships between components within communities and NSC 696921; 4) MDR: the compounds that were significantly associated with the NSC 696921.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0186186224062458 0.023317506
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0186186224062458 0.095749883
NSC 725098 Null 0.0186186224062458 0.114322
NSC 730691 Null 0.0186186224062458 0.1215615
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0186186224062458 0.1951098
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0186186224062458 0.38638217
NSC 744688 Null 0.0186186224062458 0.14375302
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0186186224062458 0.18312475
NSC 752346 Null 0.0186186224062458 0.078155776
NSC 752761 Null 0.0186186224062458 -0.13819284
Total:170  Current:93    [First] [Prev] [Next] [Last]